The Christine E. Lynn Women’s Health & Wellness Institute at Boca Raton Regional Hospital and GE Healthcare, today, announced a first-of-its kind agreement between these two leading institutions to advance breast healthcare. Under the agreement, GE Healthcare has established the Institute as a national show site and identified the framework for developing a training Center of Excellence rooted in education and awareness around GE Healthcare’s breast cancer screening and diagnostic technologies, care pathways and outcomes targeted to meet the unique needs of all women.
Effectively combatting breast cancer requires cutting-edge technology, dedication and experts across multi-disciplinary fields. The Christine E. Lynn Women’s Health & Wellness Institute will showcase GE Healthcare’s most comprehensive set of advanced imaging tools for detecting breast cancer in one clinical setting. As a national show site, its specialists and support staff will welcome visitors from around the world to share insights into its own clinical protocols and expertise related to GE Healthcare’s interconnected breast care solution.
“Being recognized as a GE Healthcare national show site is a testament to the dedication, training and expertise of our clinical staff to utilize advanced technology to better serve our patients,” said Kathy Schilling, MD, Medical Director of the Christine E. Lynn Women’s Health & Wellness Institute. “In this era of outcomes and value-based healthcare, a long-standing collaboration such as the one we have with GE Healthcare is critical to delivering on our commitment to confidently meet the unique medical needs of every woman.”
MORE “PERSONALIZED BREAST CARE IS HERE: BOCA RATON REGIONAL HOSPITAL AND GE HEALTHCARE JOIN FORCES TO TACKLE CANCER”
Officials at Boca Raton Regional Hospital today announced the establishment of the Fern F. Steinfeld Transcatheter Aortic Valve Replacement Center. This latest component of the Hospital’s Christine E. Lynn Heart & Vascular Institute (LHVI) now provides a highly therapeutic treatment option for patients with symptomatic aortic stenosis and who are considered a high risk for standard valve replacement surgery.
Aortic valve stenosis is a type of heart disease in which the valve that regulates blood flow from the heart is narrowed and prevented from opening fully. It is estimated that patients with severe aortic stenosis have about a 50 percent chance of living just two years without aortic valve replacement.
Regretfully, many of these patients are of advanced age or have co-existing health issues that disqualify them for traditional valve replacement. Transcatheter Aortic Valve Replacement or TAVR is a minimally invasive surgical technique that greatly reduces the procedural risk for these individuals.
MORE “TRANSCATHETER AORTIC VALVE REPLACEMENT CENTER ESTABLISHED AT BOCA REGIONAL”
Palm Beach County is the cheapest place in the developed world to run a medical device plant, according to a study by The Boyd Co., a location consultant in Princeton, New Jersey.
The Boyd Co. estimated the cost of running a hypothetical 100,000-square-foot plant with 100 workers in 29 locations in Europe and North America. The annual budget ranges from a high of $10.9 million in Munich to a low of $3.6 million in cities along the Mexican side of the U.S. border.
MORE “PALM BEACH COUNTY COUNTRY’S CHEAPEST PLACE TO RUN MEDICAL DEVICE PLANT, STUDY FINDS”